EUVIMEDEUVIMED entdecken
Crossref

Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4 – LPS ‐Mediated Migration in Triple‐Negative Breast Cancer Cells

S K Batin Rahaman, Satyajit Halder, Kuldeep K Roy, Pallab K Halder, Utsab Debnath, Kuladip Jana

Chemical Biology & Drug Design · 2025-03 · 105 (3)

DOI: 10.1111/cbdd.70089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 24.03.2025. Verfasst von S K Batin Rahaman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Science, School of Health Sciences and Technology, UPES, Dehradun, India. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Cell Movement, Lipopolysaccharides, Cell Proliferation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Toll‐like receptor 4 (TLR4) signaling pathway plays a leading role in triggering proinflammatory responses by targeting lipopolysaccharide (LPS) molecules from different bacteria. Meanwhile, it is also expressed at higher levels in breast cancer cells than in normal breast tissue. After LPS binding, it initiates downstream signaling pathways that promote inflammation and cell apoptosis. Thus, targeting TLR4–LPS presents a promising dual therapeutic strategy for breast cancer treatment by not only inhibiting tumor growth but also reducing inflammation within the tumor microenvironment. To achieve this, the discovery of a new antiinflammatory agent is needed to reduce LPS‐mediated cancer cell proliferation and migration. In this study, a series of 4‐aminoquinoline–thiazolidinone hybrid analogs (4a‐m) have been synthesized to explore their antiinflammatory as well as anticancer activity to find a new lead. Among them, 4e revealed the most promising antiinflammatory (IC50 = 2.38 ± 0.77 μM) as well as anticancer activity (IC50 = 3.26 ± 1.06 μM) in RAW 267.7 cell line and triple‐negative breast cancer (TNBC) cell line, respectively. Further structure–activity relationship study followed by MD simulation analysis was carried out to identify probable binding residues of TLR4 which may play a significant role in developing antiinflammatory activity for promoting cell apoptosis in cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4Cell MovementLipopolysaccharidesCell ProliferationAntineoplastic AgentsTriple Negative Breast NeoplasmsThiazolidinesAminoquinolinesMolecular Docking SimulationHumansCell Line, TumorMiceFemaleAnimalsStructure-Activity RelationshipRAW 264.7 CellsAnti-Inflammatory AgentsApoptosis

Stichwörter der Autor:innen

4‐amino quinoline–thiazolidinoneMD simulation analysisToll‐like receptor 4 (TLR4)anticancer activityantiinflammatory activitylipopolysaccharide (LPS)structure–activity relationship (SAR) study

Substanzen

Toll-Like Receptor 4LipopolysaccharidesAntineoplastic AgentsThiazolidinesAminoquinolines4-aminoquinolineTLR4 protein, humanAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Science, School of Health Sciences and Technology, UPES, Dehradun, India.
  • Department of Molecular Medicine, Bose Institute, Kolkata, India.
  • School of Natural Product Studies, Jadavpur University, Kolkata, India.

Zitieren

APA

Batin Rahaman, S. K., Halder, S., Roy, K. K., Halder, P. K., Debnath, U., & Jana, K. (2025). Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4 – LPS ‐Mediated Migration in Triple‐Negative Breast Cancer Cells. Chemical Biology & Drug Design, 105(3). https://doi.org/10.1111/cbdd.70089

Vancouver

Batin Rahaman SK, Halder S, Roy KK, Halder PK, Debnath U, Jana K. Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4 – LPS ‐Mediated Migration in Triple‐Negative Breast Cancer Cells. Chemical Biology & Drug Design. 2025;105(3). doi:10.1111/cbdd.70089

BibTeX
@article{BatinRahaman2025,
  author = {Batin Rahaman, S K and Halder, Satyajit and Roy, Kuldeep K and Halder, Pallab K and Debnath, Utsab and Jana, Kuladip},
  title = {Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4 – LPS ‐Mediated Migration in Triple‐Negative Breast Cancer Cells},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  volume = {105},
  number = {3},
  doi = {10.1111/cbdd.70089}
}
Kostenlos starten →